English: Thank you to David Melding. One of the reasons that I asked to contribute today was to pay tribute to the work of my constituent Jo Cozens, who is chair of the Organisation for Anti-Convulsant Syndrome charity, or OACS. For several years, Jo has campaigned tirelessly on behalf of families across the UK touched by foetal anti-convulsant syndromes. Jo does this out of first-hand experience, having been given sodium valproate to treat epilepsy, with which she was diagnosed as a teenager. Later on, on the advice of a doctor at the time, she continued to take this medication while pregnant with her son Tomas. Tomas is now a teenager and he's faced multiple health challenges all his life, having been diagnosed with foetal valproate neurodevelopmental effects, and it's through her work with OACS that Jo's discovered that many other families have been affected like her, due to mothers taking sodium valproate when pregnant. Jo's made it her mission to ensure that Governments across the UK legislate so that experiences like hers, and of other families affected, never happen again, and that's why she wants to see the implementation of the Cumberlege review's recommendations. I would be grateful to the Minister if he, as David Melding said, could provide us with an update today as to where we are with this in Wales. He will be aware that I've written to him about this, and that Jo has met with his officials, although not since last September. We're really keen to see progress on this, for the benefit of Jo, Tomas and all those who have been affected like them.
Welsh: Diolch i David Melding. Un o'r rhesymau y gofynnais am gael cyfrannu heddiw oedd er mwyn talu teyrnged i waith fy etholwr Jo Cozens, sy'n gadeirydd yr elusen, y Gymdeithas Syndrom Gwrthepileptig, neu OACS. Ers sawl blwyddyn, mae Jo wedi ymgyrchu'n ddiflino ar ran teuluoedd ledled y DU sydd wedi'u heffeithio gan syndromau gwrthepileptig y ffetws. Mae Jo yn gwneud hyn yn sgil profiad uniongyrchol, ar ôl cael sodiwm falproat i drin epilepsi y cafodd ddiagnosis ohono yn ei harddegau. Yn ddiweddarach, ar gyngor meddyg ar y pryd, parhaodd i gymryd y feddyginiaeth hon tra'n feichiog gyda'i mab Tomas. Mae Tomas bellach yn ei arddegau ac mae wedi wynebu heriau iechyd lluosog drwy gydol ei oes, ar ôl cael diagnosis o effeithiau niwroddatblygiadol falproat y ffetws, a thrwy ei gwaith gydag OACS y darganfu Jo fod llawer o deuluoedd eraill wedi cael eu heffeithio fel hithau, wedi i famau gymryd sodiwm falproat pan oeddent yn feichiog. Mae Jo wedi'i gwneud yn genhadaeth i sicrhau bod Llywodraethau ledled y DU yn deddfu fel nad yw profiadau fel ei phrofiad hi, a theuluoedd eraill yr effeithiwyd arnynt, byth yn digwydd eto, a dyna pam ei bod hi eisiau gweld argymhellion adolygiad Cumberlege yn cael eu gweithredu. Byddwn yn ddiolchgar i'r Gweinidog, fel y dywedodd David Melding, os gall roi'r wybodaeth ddiweddaraf inni heddiw ynglŷn â ble rydym arni gyda hyn yng Nghymru. Fe fydd yn ymwybodol fy mod wedi ysgrifennu ato ynglŷn â hyn, a bod Jo wedi cyfarfod â'i swyddogion, er na ddigwyddodd hynny ers mis Medi diwethaf. Rydym yn awyddus iawn i weld cynnydd ar hyn, er budd Jo, Tomas a phawb yr effeithiwyd arnynt yn yr un modd.